The inhibition of basal insulin hypersecretion due to obesity and the inhibition of glucose-stimulated insulin secretion were identified after the direct in vitro administration of rimonabant in islets [164]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.